Burkhard Jansen
Chief Tech/Sci/R&D Officer bij DERMTECH, INC.
Actieve functies van Burkhard Jansen
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| DERMTECH, INC. | Chief Tech/Sci/R&D Officer | 03-09-2019 | - |
Loopbaan van Burkhard Jansen
Eerdere bekende functies van Burkhard Jansen
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
DermTech Operations, Inc.
 DermTech Operations, Inc. Medical SpecialtiesHealth Technology DermTech Operations, Inc. engages in the provision of molecular dermatology. It develops products that facilitate the early detection of skin cancers, assess inflammatory diseases, and customize drug treatments. The firm's products include adhesive skin collection kit, pigmented lesion assay (PLA), nevome, inflammatory disease and carcinome. The company was founded by Lawrence A. Rheins in 1996 and is headquartered in La Jolla, CA. | Chief Tech/Sci/R&D Officer | 01-01-2017 | 01-08-2019 |
| Corporate Officer/Principal | 01-10-2015 | 01-01-2017 | |
OncoGenex Pharmaceuticals, Inc.
 OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | Chief Tech/Sci/R&D Officer | - | - |
| University of Vienna | Corporate Officer/Principal | - | - |
Novelix Pharmaceuticals, Inc.
 Novelix Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Novelix Pharmaceuticals, Inc. is a biotechnology company. The firm manufactures pharmaceutical products. It focuses on lung, colon and dermato-oncology indications. The company was founded by Jeremy Teraoka and Burkhard Jansen in 2005 and is headquartered in Encinitas, CA. | Chief Executive Officer | 01-01-2005 | - |
| Founder | 01-02-2010 | - | |
| President | 01-01-2005 | - |
Opleiding van Burkhard Jansen
| University of Graz | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| Oostenrijk | 3 |
Operationeel
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 2 |
| Chief Executive Officer | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
| Health Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| DERMTECH, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Novelix Pharmaceuticals, Inc.
Novelix Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Novelix Pharmaceuticals, Inc. is a biotechnology company. The firm manufactures pharmaceutical products. It focuses on lung, colon and dermato-oncology indications. The company was founded by Jeremy Teraoka and Burkhard Jansen in 2005 and is headquartered in Encinitas, CA. | Health Services |
DermTech Operations, Inc.
DermTech Operations, Inc. Medical SpecialtiesHealth Technology DermTech Operations, Inc. engages in the provision of molecular dermatology. It develops products that facilitate the early detection of skin cancers, assess inflammatory diseases, and customize drug treatments. The firm's products include adhesive skin collection kit, pigmented lesion assay (PLA), nevome, inflammatory disease and carcinome. The company was founded by Lawrence A. Rheins in 1996 and is headquartered in La Jolla, CA. | Health Technology |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | Health Technology |
- Beurs
- Insiders
- Burkhard Jansen
- Ervaring
